Hasil Pencarian  ::  Simpan CSV :: Kembali

"This book presents many of the major, relevant advances in molecular pathology that are occurring in the field of pediatric oncology and will serve as a useful overview for resident and attending physicians as well as scientists interested in understanding the molecular pathology of pediatric cancer in the context of clinical medicine. Chapters are based upon organ systems, and each is written by an expert or pair of experts in their field with subspecialty training and extensive clinical experience. Each chapter describes a variable number of tumors and includes an overview of the classification system and clinicopathological characteristics of each tumor. This is followed by a discussion of the molecular pathology relevant to a specific tumor, including specific molecular markers of the tumors, methods used for diagnosis or clinical management, clinical significance of the markers, and if appropriate, a description or discussion of current activities in translational research or issues that need to be addressed in the future. "

""Now thoroughly updated to include new advances in the field, and with regular content updates to the eBook, Principles and Practice of Pediatric Oncology, 7th Edition remains the gold standard text for the care and research of children with cancer. This authoritative reference is the single most comprehensive resource on the biology and genetics of childhood cancer and the diagnosis, multimodal treatment, and long-term management of young patients with cancer. Also addressed are a broad array of topics on the supportive and psychosocial aspects of care of children and families. Covering virtually every aspect of the breadth and depth of childhood cancer, this 7th Edition provides expert guidance on state-of-the-art, multidisciplinary care for children and families"--Publisher's description."

"In this volume Dr Hui has brought together a comprehensive overview of gestational trophoblastic disease that includes all the currently recognized entities: complete and partial hydatidiform moles, placental site trophoblastic tumor, epithelioid trophoblastic tumor, gestational choriocarcinoma, persistent gestational trophoblastic neoplasia, placental site nodule and exaggerated placental site reaction. Each entity is reviewed in detail, with emphasis on genetic background, clinical presentation, pathologic findings and ancillary studies, differential diagnosis and clinicopathological correlations.Descriptions of the pathology are supported by numerous excellent photomicrographs. Recent advances in our understanding of the genetics of gestational trophoblastic diseases are stressed. Introductory chapters cover the developmental biology of the placenta and the genetic basis of gestational trophoblastic disease, and one chapter is devoted to the molecular diagnosis of gestational trophoblastic disease. This chapter includes a review of the use of short tandem repeat (STR) genotyping which is of particular value in the diagnosis of hydatidiform moles. The final chapter covers clinical aspects of gestational trophoblastic disease, including treatment. The text throughout is current and thoroughly referenced. "

"Molecular pathology of lung cancer bridges the gap between the molecular specialist and the clinical practitioner, including the surgical pathologist who now has a key role in decisions regarding molecular targeted therapy for lung cancer. Molecular pathology of lung cancer provides the latest information and current insights into the molecular basis for lung cancer, including precursor and preinvasive lesions, molecular diagnosis, molecular targeted therapy, molecular prognosis, molecular radiology and related fields for lung cancer generally and for the specific cell types. As many fundamental concepts about lung cancer have undergone revision in only the past few years, this book will likely be the first to comprehensively cover the new molecular pathology of lung cancer. It provides a foundation in this field for pathologists, medical oncologists, radiation oncologists, thoracic surgeons, thoracic radiologists and their trainees, physician assistants, and nursing staff."

"This book provides a state-of-the-art approach to the molecular basis of hematologic diseases and its translation into improved diagnostics and novel therapeutic strategies. Several representative hemato-oncologic malignancies are analyzed in detail: acute lymphoblastic leukemia, acute myeloid leukemia, B-cell Non-Hodgkin lymphomas, multiple myeloma, chronic lymphocytic leukemia, chronic myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. Experts in the field describe the molecular methods applied for modern diagnostics and therapies, such as hematopoietic stem cell transplantation, donor recipient matching, banking of biological material, analyses of post-transplant chimerism, and minimal residual disease monitoring. The volume concludes with an extensive section comprising thorough step-by-step protocols of molecular techniques in hematology, all of them validated in the authors? own laboratories."

"Prevalensi kanker payudara pada tahun 2020 menduduki peringkat pertama di dunia maupun di Indonesia. Pencarian obat antikanker menggunakan metode komputasi dinilai lebih efektif dan selektif. Asam galat dan turunannya (ester dan amida) merupakan senyawa yang memiliki aktivitas biologis seperti antikanker. Tujuan dari studi ini adalah melakukan analisis secara in-siliko dan in-vitro terhadap senyawa turunan asam galat (N-Alkil galamida) sebagai agen apoptosis sel kanker payudara MCF7. Sebelas senyawa N-Alkil galamida yang telah disintesis dilakukan studi in-siliko meliputi, interaksi protein-protein, interaksi obat-protein, analisis ADMET dan pemodelan molekuler. Tiga senyawa terbaik berdasarkan studi in-siliko diuji aktivitas sitotoksisitasnya pada sel MCF7 menggunakan metode MTT dan analisis apoptosis menggunakan annexin V-FITC/PI dengan flow cytometry. Protein target terpilih, yaitu JUN, AKT1, CASP3 dan CASP7. Senyawa N-Oktil galamida, N-Ters-Butil galamida dan N-Isoamil galamida merupakan tiga senyawa terbaik. Senyawa asam galat dan turunannya, secara analisis prediksi ADMET termasuk dalam kategori aman sebagai kandidat obat. Aktivitas sitotoksik ketiga senyawa tersebut dinyatakan dengan nilai IC50 berturut-turut adalah 205.2 ± 0,44 μM, 372.6 ± 4,09 μM, dan 441.7 ± 1,41 μM. Aktivitas apoptosis mencapai 55 hingga 56% dibandingkan dengan kontrol sel. Senyawa N-Oktil galamida, N-Ters-Butil galamida dan N-Isoamil galamida berpotensi sebagai agen apoptosis pada sel kanker payudara MCF7.

---

The prevalence of breast cancer in 2020 is ranked first in the world and in Indonesia. Searching for anticancer drugs using computational methods is considered more effective and selective. Gallic acid and its derivatives (esters and amides) are compounds that have biological activities such as anticancer. In this study, N-Alkyl gallamides were analyzed in-vitro and in-silico for their potential to act as apoptotic agents for MCF7 breast cancer cells. In-silico investigations on eleven N-alkyl gallamide compounds, including protein-protein interactions, drug-protein interactions, ADMET analysis, and molecular modelling, have been conducted. The three best compounds based on in-silico studies were tested for cytotoxicity activity on MCF7 cells using the MTT assay and apoptosis analysis using annexin V-FITC/PI with flow cytometry. Selected target proteins, namely JUN, AKT1, CASP3 and CASP7. According to ADMET study, gallic acid and their derivatives are safe as therapeutic candidates. The cytotoxic activities of the three compounds were expressed by IC50 values of 205.2 ± 0.44 μM, 372.6 ± 4.09 μM, and 441.7 ± 1.41 μM, respectively. Apoptotic activity reached 55 to 56% compared to control cells. The N-Octyl gallamide, N-Ters-Butyl gallamide and N-Isoamil gallamide compounds have the potential as apoptotic agents in MCF7 cells."

"This third volume of the Springer series discussing pediatric cancer focuses on diagnosing, treating, and assessing the future course of malignant brain neoplasms in children. In addition to a general introduction to the principals involved, the material includes vital research in molecular genetics, a major contribution to the molecular characterization of solid tumors, which will define new biomarkers of the disease and identify molecular pathways. The volume includes presentations of present and future therapies. The volume also explains AT/RT’s dissemination to the cerebral fluid, the molecular mechanisms underlying the progression of medulloblastoma, and the importance of gamma knife radiosurgery during multimodality management of medulloblastoma/PNET tumors. Other topics discussed include using magnetic resonance imaging for diagnosing retinoblastoma, and mapping the effects of radiotherapy in low-grade glioma in children. Information on alterations in cell-cycle regulators that are influenced by tumor suppressor genes and oncogenes is detailed. Contributors provide recommendations concerning non-narcotic analgesic routines for children recovering from cranial and spinal surgery. "